Research and Markets: Germany Healthcare, Regulatory and Reimbursement Landscape Report 2015
April 01 2015 - 6:35AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/lbvxd2/countryfocus)
has announced the addition of the "CountryFocus: Healthcare,
Regulatory and Reimbursement Landscape - Germany" report to their
offering.
The report is an essential source of information on and analysis
of the healthcare, regulatory and reimbursement landscape in
Germany. It identifies the key trends in the country's healthcare
market and provides insights into its demographic, regulatory, and
reimbursement landscape and healthcare infrastructure. Most
importantly, the report provides valuable insights into the trends
and segmentation of its pharmaceutical and medical device markets.
It uses data and information sourced from proprietary databases,
secondary research, and in-house analysis by a team of industry
experts.
Germany's increasingly elderly population and its associated
disease burden are key drivers of its pharmaceutical market. In
2013, the elderly accounted for 27.1% of the total population,
expected to increase at Compound Annual Growth Rate (CAGR) of 1.2%
to 29.5% in 2020.
In 2008, healthcare expenditure as percentage of Gross Domestic
Product (GDP) amounted to 10.7%, which increased to an estimated
11.5% in 2013. In 2011, the government initiated a new plan -
Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) - to curb healthcare
expenditure.
The pharmaceuticals market was worth $54.7 billion in 2008 and
is projected to have reached a value of approximately $65 billion
by 2020 at a CAGR of 1.4%. The German medical device market was
valued at $18.9 billion in 2008 and is projected to grow at a CAGR
of 5.1% to reach $34.4 billion in 2020.
These positive growth trends can be primarily attributed to
- The rising prevalence of chronic disease
- Universal health coverage
- Well established and centralized regulatory procedure
Scope
- An overview of the pharmaceuticals and medical device markets,
consisting of market size, segmentation, and key drivers and
barriers
- Profiles and SWOT analyses of the major players in the
pharmaceutical market - Novartis, Pfizer, Teva Pharmaceutical,
Sanofi and Roche - and profiles and SWOT analyses of the major
players in the medical device market - Medtronic, Siemens
Healthcare, F. Hoffmann-La Roche, Philips Healthcare and GE Abbott
Laboratories
- Insightful review of the reimbursement and regulatory
landscape, with analysis covering details of the country's
healthcare reimbursement process, regulatory agencies and the
approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment,
covering economic indicators, demographics, healthcare
infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth
in the healthcare market
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Overview of Pharmaceutical and Medical Device Market
4 Market Access
5 Country Analysis
6 Opportunities and Challenges
7 Appendix
For more information visit
http://www.researchandmarkets.com/research/lbvxd2/countryfocus
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals